Search

Your search keyword '"Bruce-Keller, Annadora"' showing total 407 results
Start Over Author "Bruce-Keller, Annadora"
407 results on '"Bruce-Keller, Annadora"'

1. What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice: Summary from a Pennington Scientific Symposium

Author

Qualls‐Creekmore, Emily, Marlatt, Kara L, Aarts, Esther, Bruce‐Keller, Annadora, Church, Tim S, Clément, Karine, Fisher, Jennifer O, Gordon‐Larsen, Penny, Morrison, Christopher D, Raybould, Helen E, Ryan, Donna H, Schauer, Philip R, Spector, Alan C, Spetter, Maartje S, Stuber, Garret D, Berthoud, Hans‐Rudolf, and Ravussin, Eric

Subjects
Biological Sciences, Biomedical and Clinical Sciences, Public Health, Health Sciences, Nutrition and Dietetics, Prevention, Behavioral and Social Science, Obesity, Nutrition, Cancer, Stroke, Oral and gastrointestinal, Cardiovascular, Metabolic and endocrine, Exercise, Feeding Behavior, Food Preferences, Humans, Endocrinology & Metabolism
Abstract

This review details the proceedings of a Pennington Biomedical scientific symposium titled, "What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice." The symposium was designed to review the literature about energy homeostasis, particularly related to food choice and feeding behaviors, from psychology to physiology. This review discusses the intrinsic determinants of food choice, including biological mechanisms (genetics), peripheral and central signals, brain correlates, and the potential role of the microbiome. This review also address the extrinsic determinants (environment) of food choice within our physical and social environments. Finally, this review reports the current treatment practices for the clinical management of eating-induced overweight and obesity. An improved understanding of these determinants will inform best practices for the clinical treatment and prevention of obesity. Strategies paired with systemic shifts in our public health policies and changes in our "obesogenic" environment will be most effective at attenuating the obesity epidemic.

Published
2020

30. Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphine

Author

Duncan, Marilyn J., Bruce-Keller, Annadora J., Conner, Clayton, Knapp, Pamela E., Xu, Ruquiang, Nath, Avindra, and Hauser, Kurt F.

Subjects
HIV infection -- Development and progression, HIV infection -- Genetic aspects, Genetic transcription -- Research, Morphine -- Health aspects, Circadian rhythms -- Research, Biological sciences
Abstract

Patients with human immunodeficiency virus (HIV) infection exhibit changes in sleep patterns, motor disorders, and cognitive dysfunction; these symptoms may be secondary to circadian rhythm abnormalities. Studies in mice have shown that intracerebral injection of an HIV protein, transactivator of transcription (Tat), alters the timing of circadian rhythms in a manner similar to light. Therefore, we tested the hypothesis that chronic Tat expression alters circadian rhythms, especially their entrainment to a light-dark (LD) cycle, by using transgenic mice in which Tat expression in the brain was induced via a doxycycline (DOX)-sensitive, glial fibrillary-associated, protein-restricted promoter. Because opiate substance abuse, which shares comorbidity with HIV infection, also disrupts sleep, a final experiment assessed the effects of morphine exposure on circadian rhythms in wild-type and Tat transgenic mice. Mice housed in cages equipped with running wheels were fed chow with or without DOX. Experiment 1 revealed a small but significant (P < 0.05) difference between groups in the phase angle of entrainment and a 15% decrease in the wheel running in the DOX group (P < 0.005). During exposure to constant darkness, DOX did not alter the endogenous period length of the circadian rhythm. Experiment 2 investigated the effect of DOX on circadian rhythms in wild-type and Tat(+) mice during exposure to a normal or phase-shifted LD cycle, or morphine treatment without any change in the LD cycle. Tat induction significantly decreased wheel running but did not affect entrainment to the normal or shifted LD cycle. Morphine decreased wheel running without altering the phase angle of entrainment, and the drug's effects were independent of Tat induction. In conclusion, these findings suggest that chronic brain expression of Tat decreases locomotor activity and the amplitude of circadian rhythms, but does not affect photic entrainment or reentrainment of the murine circadian pacemaker. human immunodeficiency virus-acquired immunodeficiency syndrome; morphine; opioid drug abuse; locomotor activity; human immunodeficiency virus encephalitis

Published
2008

33. What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice: Summary from a Pennington Scientific Symposium.

Author

Qualls-Creekmore, Emily, Qualls-Creekmore, Emily, Marlatt, Kara L, Aarts, Esther, Bruce-Keller, Annadora, Church, Tim S, Clément, Karine, Fisher, Jennifer O, Gordon-Larsen, Penny, Morrison, Christopher D, Raybould, Helen E, Ryan, Donna H, Schauer, Philip R, Spector, Alan C, Spetter, Maartje S, Stuber, Garret D, Berthoud, Hans-Rudolf, Ravussin, Eric, Qualls-Creekmore, Emily, Qualls-Creekmore, Emily, Marlatt, Kara L, Aarts, Esther, Bruce-Keller, Annadora, Church, Tim S, Clément, Karine, Fisher, Jennifer O, Gordon-Larsen, Penny, Morrison, Christopher D, Raybould, Helen E, Ryan, Donna H, Schauer, Philip R, Spector, Alan C, Spetter, Maartje S, Stuber, Garret D, Berthoud, Hans-Rudolf, and Ravussin, Eric

Abstract

This review details the proceedings of a Pennington Biomedical scientific symposium titled, "What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice." The symposium was designed to review the literature about energy homeostasis, particularly related to food choice and feeding behaviors, from psychology to physiology. This review discusses the intrinsic determinants of food choice, including biological mechanisms (genetics), peripheral and central signals, brain correlates, and the potential role of the microbiome. This review also address the extrinsic determinants (environment) of food choice within our physical and social environments. Finally, this review reports the current treatment practices for the clinical management of eating-induced overweight and obesity. An improved understanding of these determinants will inform best practices for the clinical treatment and prevention of obesity. Strategies paired with systemic shifts in our public health policies and changes in our "obesogenic" environment will be most effective at attenuating the obesity epidemic.

Published
2020

36. Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C

Author

Bradshaw, Emily L., Li, Xiang-An, Guerin, Theresa, Everson, William V., Wilson, Melinda E., Bruce-Keller, Annadora J., Greenberg, Richard N., Guo, Ling, Ross, Stuart A., and Smart, Eric J.

Subjects
Low density lipoprotein receptors -- Research, Ubiquitin-proteasome system -- Research, Macrophages -- Research, Biological sciences
Abstract

HIV protease inhibitors are important pharmacological agents used in the treatment of HIV-infected patients. One of the major disadvantages of HIV protease inhibitors is that they increase several cardiovascular risk factors, including the expression of CD36 in macrophages. The expression of CD36 in macrophages promotes the accumulation of cholesterol, the development of foam cells, and ultimately atherosclerosis. Recent studies have suggested that a-tocopherol can prevent HIV protease inhibitor-induced increases in macrophage CD36 levels. Because of the potential clinical utility of using a-tocopherol to limit some of the side effects of HIV protease inhibitors, we tested the ability of a-tocopherol to prevent ritonavir, a common HIV protease inhibitor, from inducing atherosclerosis in the LDL receptor (LDLR) null mouse model. Surprisingly, [alpha]-tocopherol did not prevent ritonavir-induced atherosclerosis. However, cotreatment with the nucleoside reverse transcriptase inhibitors (NRTIs), didanosine or D4T, did prevent ritonavir-induced atherosclerosis. Using macrophages isolated from LDLR null mice, we demonstrated that the NRTIs prevented the upregulation of CD36 and cholesterol accumulation in macrophages. Treatment of LDLR null mice with NRTIs promoted the ubiquitination and downregulation of protein kinase C[alpha] (PKC). Previous studies demonstrated that HIV protease inhibitor activation of PKC was necessary for the upregulation of CD36. Importantly, the in vivo inhibition of PKC with chelerythrine prevented ritonavir-induced upregulation of CD36, accumulation of cholesterol, and the formation of atherosclerotic lesions. These novel mechanistic studies suggest that NRTIs may provide protection from one of the negative side effects associated with HIV protease inhibitors, namely the increase in CD36 levels and subsequent cholesterol accumulation and atherogenesis. CD36; macrophage; proteasome; low-density lipoprotein receptor

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results